Page 2 - Kumar Emany News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kumar emany. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kumar Emany Today - Breaking & Trending Today

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Purchased by Tokio Marine Asset Management Co. Ltd.

Tokio Marine Asset Management Co. Ltd. increased its stake in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 11.2% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 12,900 shares of the biotechnology company’s stock after purchasing an additional 1,300 […] ....

United States , Sravan Kumar Emany , Lazard Asset Management , News Ratings For Ironwood Pharmaceuticals Daily , Quarter For Ironwood Pharmaceuticals , Ironwood Pharmaceuticals Inc , Tokio Marine Asset Management Co , Ironwood Pharmaceuticals Price Performance , Exchange Commission , Securities Exchange Commission , Goodman Advisory Group , Ironwood Pharmaceuticals , Tokio Marine Asset Management , Free Report , Marine Asset Management , Advisory Group , Asset Management , Captrust Financial Advisors , Financial Advisors , Kumar Emany , Get Free Report , Ironwood Pharmaceuticals Daily , Nasdaq Irwd , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Louisiana State Employees Retirement System Raises Holdings in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD)

Louisiana State Employees Retirement System raised its holdings in shares of Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 14.0% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 70,900 shares of the biotechnology company’s stock after acquiring an additional 8,700 shares during the quarter. Louisiana State Employees Retirement System’s holdings in Ironwood Pharmaceuticals were […] ....

Baja California Sur , United States , Sravan Kumar Emany , Renaissance Technologies , Ironwood Pharmaceuticals Inc , Blackrock Inc , News Ratings For Ironwood Pharmaceuticals Daily , Quarter For Ironwood Pharmaceuticals , Ironwood Pharmaceuticals Company Profile , Ironwood Pharmaceuticals Stock Down , Ironwood Pharmaceuticals , Millennium Management , Securities Exchange Commission , Dimensional Fund Advisors , Louisiana State Employees Retirement System , Free Report , State Employees Retirement System , Street Corp , Fund Advisors , Kumar Emany , Exchange Commission , Pharmaceuticals Stock Down , Get Free Report , Visit Holdingschannel , Ironwood Pharmaceuticals Daily , Nasdaq Irwd ,

Ironwood Pharmaceuticals (NASDAQ:IRWD) Now Covered by JMP Securities

JMP Securities began coverage on shares of Ironwood Pharmaceuticals (NASDAQ:IRWD – Free Report) in a research report released on Thursday, MarketBeat Ratings reports. The brokerage issued an outperform rating and a $22.00 target price on the biotechnology company’s stock. Other equities analysts also recently issued reports about the company. StockNews.com downgraded Ironwood Pharmaceuticals from a […] ....

United States , Sravan Kumar Emany , Banque Cantonale Vaudoise , Ironwood Pharmaceuticals Inc , Ironwood Pharmaceuticals Trading , Ironwood Pharmaceuticals Company Profile , News Ratings For Ironwood Pharmaceuticals Daily , Securities Exchange Commission , Goodman Advisory Group , Financial Services Group Inc , Ironwood Pharmaceuticals , Free Report , Marketbeat Ratings , Get Free Report , Kumar Emany , Exchange Commission , Advisory Group , Services Group , Cantonale Vaudoise , Ironwood Pharmaceuticals Daily , Nasdaq Irwd , Initiated Coverage , Jmp Securities ,

Q2 2025 Earnings Estimate for Ironwood Pharmaceuticals, Inc. Issued By Zacks Research (NASDAQ:IRWD)

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) – Equities research analysts at Zacks Research lifted their Q2 2025 earnings per share estimates for shares of Ironwood Pharmaceuticals in a report issued on Monday, September 25th. Zacks Research analyst A. Chakraborty now forecasts that the biotechnology company will post earnings of $0.23 per share for the […] ....

United States , Sravan Kumar Emany , Ironwood Pharmaceuticals Company Profile , Ironwood Pharmaceuticals Stock , Topco Ltd , Securities Exchange Commission , Ironwood Pharmaceuticals Inc , Barclays Plc , News Ratings For Ironwood Pharmaceuticals Daily , Insider Activity At Ironwood Pharmaceuticals , Ironwood Pharmaceuticals , Tennessee Treasury Department , Osaic Holdings Inc , Ironwood Pharmaceutical , Zacks Research , Free Report , Get Free Report , Kumar Emany , Exchange Commission , Retirement System , Ironwood Pharmaceuticals Daily , Nasdaq Irwd , Earnings Estimates ,

Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Shares Sold by Duality Advisers LP

Duality Advisers LP lessened its position in Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Free Report) by 54.9% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 33,811 shares of the biotechnology company’s stock after selling 41,198 shares during the period. Duality Advisers LP’s holdings in Ironwood Pharmaceuticals were worth […] ....

United States , Piper Sandler , Sravan Kumar Emany , Ironwood Pharmaceuticals Trading , Ironwood Pharmaceuticals Inc , Goodman Advisory Group , Quarter For Ironwood Pharmaceuticals , Lazard Asset Management , Ironwood Pharmaceuticals Company Profile , Insider Transactions At Ironwood Pharmaceuticals , News Ratings For Ironwood Pharmaceuticals Daily , Ironwood Pharmaceuticals , Duality Advisers , Free Report , Advisory Group , Asset Management , Captrust Financial Advisors , Financial Advisors , Get Free Report , Kumar Emany , Ironwood Pharmaceuticals Daily , Nasdaq Irwd , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,